NCT06692452 2026-04-01Tazemetostat Plus CHOP in 1L T-cell LymphomaDana-Farber Cancer InstitutePhase 2 Withdrawn
NCT01677949 2017-12-02Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute LeukemiaMasonic Cancer Center, University of MinnesotaPhase 2 Withdrawn